Michele Tavecchio (Former)
1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
(
- Contribution to journal › Article
- 2021
-
Mark
Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma
(
- Contribution to journal › Article
- 2016
-
Mark
Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development
(
- Contribution to journal › Article
- 2015
-
Mark
Deletion of Cyclophilin D Impairs β-Oxidation and Promotes Glucose Metabolism
(
- Contribution to journal › Article
-
Mark
Adaptive mitochondrial reprogramming and resistance to PI3K therapy
(
- Contribution to journal › Article
- 2014
-
Mark
Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networks
(
- Contribution to journal › Article
-
Mark
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin
(
- Contribution to journal › Article
- 2013
-
Mark
Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility
(
- Contribution to journal › Article
- 2012
-
Mark
Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer
(
- Contribution to journal › Article
-
Mark
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K
(
- Contribution to journal › Article